Pall ForteBio LLC is a wholly-owned subsidiary of Pall Corp. and a division of Pall Life Sciences. Pall ForteBio develops analytical systems that enable real-time analysis of biomolecular interactions (protein quantification and characterization of protein-protein interactions, etc.) in micro-volume sample sizes, providing information on affinity, kinetics, and concentration.
Solve Scientific represents the Pioneer range from Pall Fortebio. The Pioneer and Pioneer FE systems are sensitive, 3-channel, fully-automated surface plasmon resonance (SPR) instruments, with a unique OneStep gradient injection technology. OneStep uses a single injection to acquire kinetics for a full analyte titration up to 3 orders of Magnitude – offering unmatched speed compared to other SPR-based systems. Capable of analyzing up to 768 fragments in 24 hours, the Pioneer FE system is the ideal system for fragment screening in drug discovery.
The Pioneer systems are enabling Technologies – providing more information faster than traditional methods and helping our customers in their quest to develop drugs in a more rapid and cost-effective manner. In recognition of this Pall Fortebio acquired the SensiQ’s Pioneer SPR product line to complement to its exiting range of Bio-Layer Interferometry family of label-free instruments